Your browser doesn't support javascript.
loading
Risk of secondary progressive multiple sclerosis: A longitudinal study.
Fambiatos, Adam; Jokubaitis, Vilija; Horakova, Dana; Kubala Havrdova, Eva; Trojano, Maria; Prat, Alexandre; Girard, Marc; Duquette, Pierre; Lugaresi, Alessandra; Izquierdo, Guillermo; Grand'Maison, Francois; Grammond, Pierre; Sola, Patrizia; Ferraro, Diana; Alroughani, Raed; Terzi, Murat; Hupperts, Raymond; Boz, Cavit; Lechner-Scott, Jeannette; Pucci, Eugenio; Bergamaschi, Roberto; Van Pesch, Vincent; Ozakbas, Serkan; Granella, Franco; Turkoglu, Recai; Iuliano, Gerardo; Spitaleri, Daniele; McCombe, Pamela; Solaro, Claudio; Slee, Mark; Ampapa, Radek; Soysal, Aysun; Petersen, Thor; Sanchez-Menoyo, Jose Luis; Verheul, Freek; Prevost, Julie; Sidhom, Youssef; Van Wijmeersch, Bart; Vucic, Steve; Cristiano, Edgardo; Saladino, Maria Laura; Deri, Norma; Barnett, Michael; Olascoaga, Javier; Moore, Fraser; Skibina, Olga; Gray, Orla; Fragoso, Yara; Yamout, Bassem; Shaw, Cameron.
Afiliação
  • Fambiatos A; CORe, Department of Medicine, The University of Melbourne, Melbourne, VIC, Australia.
  • Jokubaitis V; Central Clinical School, Monash University, Melbourne, VIC, Australia The Alfred, Melbourne, VIC, Australia.
  • Horakova D; Department of Neurology and Center of Clinical Neuroscience, General University Hospital and Charles University in Prague, Prague, Czech Republic.
  • Kubala Havrdova E; Department of Neurology and Center of Clinical Neuroscience, General University Hospital and Charles University in Prague, Prague, Czech Republic.
  • Trojano M; Department of Basic Medical Sciences, Neuroscience and Sense Organs, University of Bari, Bari, Italy.
  • Prat A; Hopital Notre-Dame, Montreal, QC, Canada/CHUM and Universite de Montreal, Montreal, QC, Canada.
  • Girard M; Hopital Notre-Dame, Montreal, QC, Canada/CHUM and Universite de Montreal, Montreal, QC, Canada.
  • Duquette P; Hopital Notre-Dame, Montreal, QC, Canada/CHUM and Universite de Montreal, Montreal, QC, Canada.
  • Lugaresi A; IRCCS Istituto delle Scienze Neurologiche di Bologna, UOSI Riabilitazione Sclerosi Multipla, Bologna, Italy/Dipartimento di Scienze Biomediche e Neuromotorie, Università di Bologna, Bologna, Italy.
  • Izquierdo G; Hospital Universitario Virgen Macarena, Sevilla, Spain.
  • Grand'Maison F; Neuro-Rive-Sud, Greenfield Park, QC, Canada.
  • Grammond P; CISSS de Chaudière-Appalache, Centre-Hospitalier, Levis, Canada.
  • Sola P; Department of Neuroscience, Azienda Ospedaliera Universitaria, Modena, Italy.
  • Ferraro D; Department of Neuroscience, Azienda Ospedaliera Universitaria, Modena, Italy.
  • Alroughani R; Amiri Hospital, Kuwait City, Kuwait.
  • Terzi M; Medical Faculty, Ondokuz Mayis University, Samsun, Turkey.
  • Hupperts R; Zuyderland Ziekenhuis, Sittard, The Netherlands.
  • Boz C; TU Medical Faculty, Farabi Hospital, Karadeniz Technical University, Trabzon, Turkey.
  • Lechner-Scott J; School of Medicine and Public Health, University of Newcastle, Newcastle, NSW, Australia/Department of Neurology, John Hunter Hospital, Hunter New England Health, Newcastle, NSW, Australia.
  • Pucci E; UOC Neurologia, Azienda Sanitaria Unica Regionale Marche, Macerata, Italy.
  • Bergamaschi R; IRCCS Mondino Foundation, Pavia, Italy.
  • Van Pesch V; Cliniques Universitaires Saint-Luc, Brussels, Belgium.
  • Ozakbas S; Dokuz Eylul University, Izmir, Turkey.
  • Granella F; Department of Medicine and Surgery, University of Parma, Parma, Italy.
  • Turkoglu R; Haydarpasa Numune Training and Research Hospital, Istanbul, Turkey.
  • Iuliano G; Ospedali Riuniti di Salerno, Salerno, Italy.
  • Spitaleri D; Azienda Ospedaliera di Rilievo Nazionale, San Giuseppe Moscati - Avellino, Avellino, Italy.
  • McCombe P; The University of Queensland, Brisbane, QLD, Australia/Royal Brisbane and Women's Hospital, Herston, QLD, Australia.
  • Solaro C; Ospedale P.A. Micone, Genova, Italy.
  • Slee M; Flinders University, Adelaide, SA, Australia.
  • Ampapa R; Nemocnice Jihlava, Jihlava, Czech Republic.
  • Soysal A; Bakirkoy Education and Research Hospital for Psychiatric and Neurological Diseases, Istanbul, Turkey.
  • Petersen T; Kommunehospitalet, Arhus, Denmark.
  • Sanchez-Menoyo JL; Hospital de Galdakao-Usansolo, Galdakao, Spain.
  • Verheul F; Groene Hart Ziekenhuis, Gouda, The Netherlands.
  • Prevost J; CSSS Saint-Jérôme, Saint-Jerome, QC, Canada.
  • Sidhom Y; Department of Neurology, Razi Hospital, Manouba, Tunisia.
  • Van Wijmeersch B; Rehabilitation and MS-Centre Overpelt and Hasselt University, Hasselt, Belgium.
  • Vucic S; Westmead Hospital, Sydney, NSW, Australia.
  • Cristiano E; Hospital Italiano de Buenos Aires, Buenos Aires, Argentina.
  • Saladino ML; Institute of Neurosciences Buenos Aires, Buenos Aires, Argentina.
  • Deri N; Hospital Fernandez, Buenos Aires, Argentina.
  • Barnett M; Brain and Mind Centre, Sydney, NSW, Australia.
  • Olascoaga J; Hospital Universitario Donostia-Instituto de Investigación Sanitaria Biodonostia, San Sebastian, Spain.
  • Moore F; Jewish General Hospital, Montreal, QC, Canada.
  • Skibina O; The Alfred, Melbourne, VIC, Australia.
  • Gray O; South East Trust, Belfast, UK.
  • Fragoso Y; Universidade Metropolitana de Santos, Santos, Brazil.
  • Yamout B; American University of Beirut Medical Center, Beirut, Lebanon.
  • Shaw C; Geelong Hospital, Geelong, VIC, Australia.
Mult Scler ; 26(1): 79-90, 2020 01.
Article em En | MEDLINE | ID: mdl-31397221
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Índice de Gravidade de Doença / Progressão da Doença / Esclerose Múltipla Crônica Progressiva / Esclerose Múltipla Recidivante-Remitente / Fatores Imunológicos Tipo de estudo: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Female / Humans / Male Idioma: En Revista: Mult Scler Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Índice de Gravidade de Doença / Progressão da Doença / Esclerose Múltipla Crônica Progressiva / Esclerose Múltipla Recidivante-Remitente / Fatores Imunológicos Tipo de estudo: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Female / Humans / Male Idioma: En Revista: Mult Scler Ano de publicação: 2020 Tipo de documento: Article